| Identification | Back Directory | [Name]
VAPREOTIDE | [CAS]
103222-11-3 | [Synonyms]
RC-160
BMY 41606
Octastatin
VAPREOTIDE
FCYWKVCW-NH2
Vapreotide, RC-160
VAPREOTIDE USP/EP/BP
Vapreotide，RC160，BMY 41606
Vapreotide,RC160,BMY 41606, BR
TIANFUCHEM--103222-11-3---VAPREOTIDE
D-PHE-CYS-TYR-D-TRP-LYS-VAL-CYS-TRP-NH2
H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2
D-Phe-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys(1)-L-Trp-NH2
D-Phe-Cys-Trp-D-Trp-Lys-Val-Cys-Trp-CONH2(disulfide Cys2-Cys7)
D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2 (Disulfide bridge Cys2-Cys7)
L-Tryptophanamide,D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-,cyclic (2®
L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide
10-(4-aminobutyl)-N-[1-amino-3-(1H-indol-2-yl)-1-oxopropan-2-yl]-19-[(2-amino-1-oxo-3-phenylpropyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2- | [EINECS(EC#)]
253-368-1 | [Molecular Formula]
C57H70N12O9S2 | [MDL Number]
MFCD08064685 | [MOL File]
103222-11-3.mol | [Molecular Weight]
1131.37 |
| Chemical Properties | Back Directory | [Boiling point ]
1540.9±65.0 °C(Predicted) | [density ]
1.40±0.1 g/cm3(Predicted) | [storage temp. ]
−20°C | [form ]
Solid | [pka]
9.90±0.15(Predicted) | [color ]
White to off-white | [Water Solubility ]
Water : ≥ 60 mg/mL (53.03 mM) | [Sequence]
{d-Phe}-Cys-Tyr-{d-Trp}-Lys-Val-Cys-Trp-NH2 (Disulfide bridge: Cys2-Cys7) |
| Hazard Information | Back Directory | [Uses]
Vapreotide is a synthetic somatostatin (S676750) analog predominately used for the treatment of acute variceal bleeding. | [IC 50]
NK1 |
|
|